pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Efficacy of Lower Extremity Mirror Therapy on Balance in Children With Hemiplegic Cerebral Palsy
Status: UNKNOWN
Conditions: HEMIPLEGIC CEREBRAL PALSY
Interventions: OTHER: MIRROR THERAPY
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: IMPaCT (Individualized Management Towards Patient-Centered Targets)
Status: COMPLETED
Conditions: General Medical Inpatient Conditions
Interventions: BEHAVIORAL: Patient-Centered Transition Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
Status: COMPLETED
Conditions: Influenza
Interventions: BIOLOGICAL: Inactivated Influenza Vaccine|BIOLOGICAL: Live Attenuated Influenza Vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Post-operative or Early Salvage XRT and ADT for High Risk PCa
Status: TERMINATED
Conditions: Prostate Cancer
Interventions: DRUG: antiandrogen therapy|DRUG: leuprolide acetate|RADIATION: 3-dimensional conformal radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
Status: TERMINATED
Conditions: Metastatic Melanoma
Interventions: DRUG: everolimus|DRUG: Imatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Status: COMPLETED
Conditions: Hyperlipidemia
Interventions: DRUG: AEGR-733|DRUG: placebo|DRUG: AEGR-733|DRUG: AEGR-733|DRUG: AEGR-733|DRUG: AEGR-733 and atorvastatin|DRUG: AEGR-733 and fenofibrate|DRUG: AEGR-733 and ezetimibe
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
Status: COMPLETED
Conditions: Candidemia|Invasive Candidiasis
Interventions: DRUG: Anidulafungin|DRUG: Voriconazole
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Routine Measurement of HRQOL
Status: COMPLETED
Conditions: Quality of Life|Musculoskeletal Disease|Outcome
Interventions: BEHAVIORAL: EQ-5D-5L HRQOL results be available to the attending doctor
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Online Brief CBT Intervention for Women With PCOS
Status: NOT_YET_RECRUITING
Conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries|Depression, Anxiety|Self Esteem
Interventions: BEHAVIORAL: online brief CBT intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Scandinavian Olecranon Research in the Elderly
Status: RECRUITING
Conditions: Olecranon Fracture
Interventions: PROCEDURE: Tension band wiring or plate fixation|BEHAVIORAL: Sling or a long-arm plaster
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Minfulness-Based Training Program in Bariatric Surgery Patients
Status: ACTIVE_NOT_RECRUITING
Conditions: Bariatric Surgery Candidate
Interventions: BEHAVIORAL: Mindfulness-Based Training Programme in Bariatric Surgey Patients
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
Status: RECRUITING
Conditions: Peripheral Vascular Diseases
Interventions: BEHAVIORAL: Moderate Intensity, Normal Volume Exercise Training|BEHAVIORAL: High Intensity, Normal Volume Exercise Training|BEHAVIORAL: Moderate Intensity, High Volume Exercise Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Status: COMPLETED
Conditions: Leukemia
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: oblimersen sodium|DRUG: cytarabine|DRUG: fludarabine phosphate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safety of Caffeic Acid for Esophageal Cancer
Status: UNKNOWN
Conditions: Esophagus Cancer
Interventions: DRUG: CA|DRUG: placebo group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
Status: COMPLETED
Conditions: Hookworm Infection|Hookworm Disease
Interventions: BIOLOGICAL: Na-APR-1 (M74)/Alhydrogel®|BIOLOGICAL: Na-GST-1/Alhydrogel®|BIOLOGICAL: Hepatitis B vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate
Status: COMPLETED
Conditions: Inflammation
Interventions: DRUG: BAY1834845|DRUG: BAY1834845|DRUG: Methotrexate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation
Status: ACTIVE_NOT_RECRUITING
Conditions: Chronic Pain
Interventions: DEVICE: High frequency spinal cord stimulation|DEVICE: Burst spinal cord stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Periarticular Infiltration of Local Anesthetics Versus Pericapsular Nerve Group Block for Total Hip Replacement
Status: COMPLETED
Conditions: Postoperative Pain|Weakness, Muscle|Analgesia|Motor Activity
Interventions: PROCEDURE: Ultrasound-guided pericapsular nerves group of the hip block|PROCEDURE: Pericapsular local anesthetic infiltration of the hip
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effects of PNF D2 Technique With Resistance on Pulmonary Function, Exercise Capacity and Health Status of COPD Patients
Status: UNKNOWN
Conditions: Chronic Obstructive Pulmonary Disease
Interventions: OTHER: PNF D2 technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Status: COMPLETED
Conditions: Hypertension|Cardiovascular Disease|Diabetes
Interventions: DRUG: olmesartan medoxomil / amlodipine or azelnidipine|DRUG: olmesartan medoxomil / low dose thiazide type drug
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)
Status: UNKNOWN
Conditions: COVID-19
Interventions: BIOLOGICAL: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a high-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a high-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56|BIOLOGICAL: a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Status: SUSPENDED
Conditions: Opioid Use Disorder
Interventions: DRUG: Psilocybin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
Status: COMPLETED
Conditions: Non-Squamous Non-Small Cell Lung Cancer
Interventions: DRUG: erlotinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage
Status: COMPLETED
Conditions: Postpartum Hemorrhage
Interventions: DRUG: I.V carbetocin administration|DRUG: I.V Oxytocin administration|DRUG: I.V carbetocin and tranexamic acid administration|DRUG: I.V Oxytocin and tranexamic acid administration
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine
Status: ACTIVE_NOT_RECRUITING
Conditions: Vaccination Reaction
Interventions: BIOLOGICAL: TETRALITE
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis
Status: UNKNOWN
Conditions: Knee Osteoarthritis
Interventions: DEVICE: Wearable sensor-based exercise training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Markers of Executive Attention Development in Preschoolers - Behavioral Measures in Various Populations
Status: UNKNOWN
Conditions: Attention Deficit
Interventions: BEHAVIORAL: Attention Network task (computerized)|BEHAVIORAL: Head-toes-knees-schoulders|BEHAVIORAL: Laby 5-12|BEHAVIORAL: M-ABC 2|BEHAVIORAL: Stroop animals
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Ultra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS
Status: NOT_YET_RECRUITING
Conditions: Acute Respiratory Distress Syndrome
Interventions: PROCEDURE: Ultraprotective ventilation with Extracorporeal CO2 removal|PROCEDURE: Conventional protective ventilation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Coffee Polyphenols Antioxidants
Status: COMPLETED
Conditions: Healthy
Interventions: OTHER: coffee|OTHER: coffee polyphenols mixed with placebo|OTHER: maltodextrin enriched with caffeine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
Status: COMPLETED
Conditions: Colorectal Cancer|Nausea and Vomiting
Interventions: DRUG: aprepitant|DRUG: dexamethasone|DRUG: fluorouracil|DRUG: irinotecan hydrochloride|DRUG: leucovorin calcium|DRUG: oxaliplatin|DRUG: palonosetron hydrochloride|PROCEDURE: quality-of-life assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Postoperative Pain Control After Hip Hemiarthroplasty: Intrathecal Morphine vs Periarticular Infiltration of Bupivacaine
Status: TERMINATED
Conditions: Femoral Neck Fracture
Interventions: DRUG: morphine|OTHER: control|DRUG: Bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
Status: RECRUITING
Conditions: Lymphoma, Large B-Cell, Diffuse|Central Nervous System Neoplasms, Primary
Interventions: DRUG: Lenalidomide|DRUG: Ibrutinib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESH
Status: COMPLETED
Conditions: Hiatal Hernia With Gastroesophageal Reflux Disease|Gastroesophageal Reflux|GERD
Interventions: BIOLOGICAL: Hepatic derived surgical matrix
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effects of THC and CBD on Human Episodic Memory Function
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: Tetrahydrocannabinol|DRUG: Cannabidiol|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Evaluation of Anti-mullerian Hormone(AMH) Levels as a Predictive Factor of Response to Weight Loss Treatment in Obese Infertile Women With Poly Cystic Ovary(PCOS)
Status: COMPLETED
Conditions: Infertility
Interventions: OTHER: Weight loss diet
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Iron Bioavailability of High Surface Area Ferric Phosphate
Status: COMPLETED
Conditions: Iron-deficiency
Interventions: DIETARY_SUPPLEMENT: FeSO4 fortified rice test meal|DIETARY_SUPPLEMENT: FePO4 fortified rice test meal|DIETARY_SUPPLEMENT: HiFePO4 1 fortified rice test meal|DIETARY_SUPPLEMENT: HiFePO4 2 fortified rice test meal
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
Status: UNKNOWN
Conditions: Lymphoma
Interventions: BIOLOGICAL: bleomycin sulfate|BIOLOGICAL: filgrastim|DRUG: Stanford V regimen|DRUG: doxorubicin hydrochloride|DRUG: epirubicin hydrochloride|DRUG: etoposide|DRUG: mechlorethamine hydrochloride|DRUG: prednisone|DRUG: vinblastine sulfate|DRUG: vincristine sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD
Status: COMPLETED
Conditions: Nonalcoholic Fatty Liver Disease
Interventions: OTHER: Aerobic Exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Status: COMPLETED
Conditions: Brain and Central Nervous System Tumors
Interventions: DRUG: Pamiparib|DRUG: TMZ|RADIATION: Radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Conditions: Pediatric Solid Tumor
Interventions: DRUG: Mitoxantrone Hydrochloride Liposome|DRUG: Irinotecan|DRUG: Vincristine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
Status: COMPLETED
Conditions: Gastric Cancer
Interventions: DRUG: cisplatin|DRUG: fluorouracil|DRUG: leucovorin calcium|DRUG: paclitaxel|PROCEDURE: conventional surgery|PROCEDURE: neoadjuvant therapy|RADIATION: radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies
Status: RECRUITING
Conditions: Chronic Disease
Interventions: OTHER: IMPACT Program|OTHER: usal care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass
Status: COMPLETED
Conditions: Bariatric Surgery Candidate|Gastric Bypass|Obesity, Morbid|Pouch Emptying
Interventions: OTHER: 2 years after RYGB, no intervention. MRI measurement. Observational.
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Sleepless at Scripps: An Inpatient White Noise Study
Status: RECRUITING
Conditions: White Noise|Sleep|Sleep Fragmentation|Sleep Duration
Interventions: DEVICE: Active white noise|DEVICE: Inactive white noise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Metabolic Complications Following Knee Injury in Young and Middle Aged Patients
Status: UNKNOWN
Conditions: Glucose Metabolism Disorders|Lipid Metabolism Disorders|Sedentary Lifestyle
Interventions: BIOLOGICAL: Blood and Urine sampling|RADIATION: DXA scan|BIOLOGICAL: OGTT
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Prospective Randomized Comparison of Bipolar Hemiarthroplasty and Total Hip Arthroplasty With Large Femoral Heads for the Treatment of Displaced Intracapsular Femoral Neck Fractures in the Elderly
Status: UNKNOWN
Conditions: Femoral Neck Fractures
Interventions: PROCEDURE: Total hip arthroplasty|PROCEDURE: Hemiarthroplasty
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Does the Use of the GlideRite® Endotracheal Tube in Combination With the I-gel® Improve Intubation Success Rate?
Status: COMPLETED
Conditions: Intubation|General Anesthesia
Interventions: PROCEDURE: Tracheal intubation through LMA-Fastrach®|PROCEDURE: Tracheal intubation through I-gel®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Status: RECRUITING
Conditions: Head and Neck Carcinoma|Malignant Parotid Gland Neoplasm|Maxillary Sinus Carcinoma|Nasal Cavity Carcinoma|Oral Cavity Carcinoma|Tongue Carcinoma|Tonsillar Carcinoma
Interventions: OTHER: Best Practice|OTHER: Medical Device Usage and Evaluation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
Status: COMPLETED
Conditions: Seasonal Influenza
Interventions: BIOLOGICAL: mRNA-1010|BIOLOGICAL: Licensed quadrivalent inactivated seasonal influenza vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Branch Vein Occlusion Study
Status: COMPLETED
Conditions: Macular Degeneration|Neovascularization, Pathologic|Vitreous Hemorrhage
Interventions: PROCEDURE: Macular Argon Laser Photocoagulation|PROCEDURE: Peripheral Scatter Argon Laser Photocoagulation|PROCEDURE: Scatter Argon Laser Photocoagulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
Status: TERMINATED
Conditions: Acute Respiratory Distress Syndrome|COVID19 Infection
Interventions: DRUG: Sevoflurane|DRUG: Propofol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of the ToothWave Powered Toothbrush for Extrinsic Stain Reduction (Texas)
Status: COMPLETED
Conditions: Tooth Discoloration
Interventions: DEVICE: ToothWave|DEVICE: powered toothbrush
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori
Status: COMPLETED
Conditions: H Pylori Eradication
Interventions: DRUG: Dexlansoprazole 60 mg once daily
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
Status: TERMINATED
Conditions: Cancer of the Breast
Interventions: PROCEDURE: Radio-guided sentinel node biopsy|PROCEDURE: Axillary sampling
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Status: COMPLETED
Conditions: MDS|Leukemias|Lymphomas
Interventions: DRUG: Busulfan|DRUG: Cyclophosphamide|RADIATION: Total body irradiation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
Status: COMPLETED
Conditions: Osteoporosis|Osteoporosis, Age-Related|Osteoporosis Localized to Spine|Age Related Osteoporosis|Osteoporosis Senile|Osteoporosis of Vertebrae
Interventions: DRUG: Abaloparatide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Status: NOT_YET_RECRUITING
Conditions: Cardiometabolic Disease
Interventions: DRUG: AMG 513|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease
Interventions: DEVICE: NIOV - Room Air|DEVICE: NIOV - Oxygen|DEVICE: Nasal Cannula Oxygen
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: SI-613 Study for Knee Osteoarthritis
Status: COMPLETED
Conditions: Osteoarthritis, Knee
Interventions: COMBINATION_PRODUCT: SI-613|COMBINATION_PRODUCT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: ATTUNE Cementless FB Tibial Base Clinical Study
Status: TERMINATED
Conditions: Osteoarthritis of the Knee
Interventions: DEVICE: ATTUNE Cementless CR Fixed Bearing|DEVICE: ATTUNE Cementless PS Fixed Bearing
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Status: COMPLETED
Conditions: Spondyloarthropathies
Interventions: BIOLOGICAL: CZP 200 mg Q2W|BIOLOGICAL: CZP 400 mg Q4W|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Polyethylene Insert Variances of Different Total Knee Arthroplasty System in the Same Patients
Status: UNKNOWN
Conditions: Total Knee Replacement Arthroplasty
Interventions: DEVICE: 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 and ASTX727 With Venetoclax to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Status: NOT_YET_RECRUITING
Conditions: Acute Myeloid Leukemia|Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory Myelodysplastic Syndrome
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Bone Marrow Aspiration|PROCEDURE: Bone Marrow Biopsy|DRUG: Cirtuvivint|DRUG: Decitabine and Cedazuridine|PROCEDURE: Echocardiography|PROCEDURE: Multigated Acquisition Scan|DRUG: Venetoclax
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI
Status: UNKNOWN
Conditions: Spinal Cord Injury
Interventions: BIOLOGICAL: NeuroRegen Scaffold with BMMCs transplantation|PROCEDURE: Surgical intradural decompression and adhesiolysis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Conventional Home Exercise Programs Versus Electronic Home Exercise Versus Artificial Intelligence "Virtual Therapy" for Anterior Knee Pain
Status: COMPLETED
Conditions: Patellofemoral Pain Syndrome
Interventions: OTHER: Algorithm based Exercise Videos|OTHER: PDF Exercise Sheets|OTHER: Limited Exercise Videos
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: LY2886721
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Effects of Artificial Sweeteners on Gut Microbiota and Glucose Metabolism
Status: COMPLETED
Conditions: Impaired Glucose Tolerance
Interventions: DIETARY_SUPPLEMENT: Sucralose-Aspartame|DIETARY_SUPPLEMENT: Aspartame-Sucralose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD
Status: TERMINATED
Conditions: Parkinson's Disease
Interventions: OTHER: i.c.v. infusion of sNN0031 by an Implanted infusion system|OTHER: i.c.v. infusion of aCSF by an Implanted infusion system
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
Status: RECRUITING
Conditions: Complex Regional Pain Syndrome
Interventions: DRUG: LDN|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
Status: COMPLETED
Conditions: Common Cold
Interventions: DRUG: Carbomer 980|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Status: WITHDRAWN
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy
Interventions: DRUG: H.P. Acthar® Gel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
Status: COMPLETED
Conditions: Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer
Interventions: DRUG: doxorubicin hydrochloride|DRUG: cyclophosphamide|BIOLOGICAL: bevacizumab|DRUG: paclitaxel|BIOLOGICAL: filgrastim|BIOLOGICAL: pegfilgrastim|RADIATION: radiation therapy|DRUG: tamoxifen citrate|DRUG: aromatase inhibition therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
Status: COMPLETED
Conditions: Contraception
Interventions: DRUG: NOMAC-E2|DRUG: DRSP-EE
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
Status: UNKNOWN
Conditions: Type 2 Diabetes|Obesity|Cardiovascular Disease
Interventions: DRUG: Placebo|DRUG: Ephedrine, pioglitazone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Piriformis Syndrome; Extracorporeal Shock Wave Therapy and Dry Needling
Status: COMPLETED
Conditions: Piriformis Syndrome|Extracorporeal Shock Wave Therapy
Interventions: OTHER: ESWT+stretching exercises|OTHER: Dry needling+stretching exercises
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
Status: COMPLETED
Conditions: Invasive Breast Carcinoma|Stage II Breast Cancer AJCC v6 and v7|Stage III Breast Cancer AJCC v7|Triple-Negative Breast Carcinoma
Interventions: DRUG: Atezolizumab|PROCEDURE: Biospecimen Collection|DRUG: Carboplatin|PROCEDURE: Lumpectomy|PROCEDURE: Mastectomy|DRUG: Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
Status: ACTIVE_NOT_RECRUITING
Conditions: Myelodysplastic Syndrome
Interventions: DRUG: CG200745 PPA
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Paxlovid for Treatment of Long Covid
Status: COMPLETED
Conditions: Post-acute Sequelae of SARS-CoV-2 Infection|Long COVID
Interventions: DRUG: Nirmatrelvir|DRUG: Placebo|DRUG: Ritonavir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients
Status: COMPLETED
Conditions: Kidney Failure, Chronic
Interventions: DRUG: Iopromide (Ultravist)|DRUG: Iodixanol (Visipaque)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
Status: RECRUITING
Conditions: Relapse/Refractory Multiple Myeloma
Interventions: BIOLOGICAL: DeepTag-GPRC5D Targeted CAR T-cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Status: COMPLETED
Conditions: Hepatitis B Virus
Interventions: DRUG: pegIFN|DRUG: pegIFNα-2a|DRUG: PegIFN lambda|DRUG: Entecavir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison of Combined Serratus Anterior Plane Block and Thoracic Paravertebral Block
Status: COMPLETED
Conditions: Pain, Postoperative|Serratus Anterior Plane Block|Thoracic Paravertebral Block|Multimodal Analgesia|Thoracic Surgery, Video-Assisted
Interventions: PROCEDURE: Combined Serratus Anterior Plane Block|DRUG: Thoracic Paravertebral Block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
Status: COMPLETED
Conditions: Myeloproliferative Disorders|Pulmonary Hypertension
Interventions: OTHER: Echocardiography, spiroergometry, cardiac catheterization
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Lymphoma
Interventions: DRUG: carmustine|DRUG: cytarabine|DRUG: etoposide|DRUG: thiotepa|PROCEDURE: stem cell transplant|DRUG: G-CSF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Status: COMPLETED
Conditions: Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer
Interventions: DIETARY_SUPPLEMENT: Defined Green Tea Catechin Extract|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|DRUG: Placebo|PROCEDURE: Therapeutic Conventional Surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: The PRIDE Study Probiotics on Regulation and Improving Digestive hEalth
Status: COMPLETED
Conditions: Digestive Irregularity|Digestive Discomfort|History of Straining During Bowel Movements|History of Hard or Lumpy Stools
Interventions: OTHER: Probiotic strain of Bifidobacterium|OTHER: No Bifidobacterium
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy
Status: WITHDRAWN
Conditions: Painful Myelopathy|Painful Neuropathy
Interventions: DRUG: Ziconotide|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer
Status: NOT_YET_RECRUITING
Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: DRUG: Sintilimab|DRUG: Anlotinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled Trial
Status: NOT_YET_RECRUITING
Conditions: Rectal Cancer|Rectum Neoplasm|Rectal Neoplasms|Rectal Adenocarcinoma|Low Anterior Resection Syndrome|Fecal Incontinence|Bowel Dysfunction
Interventions: BEHAVIORAL: Pelvic Floor Physiotherapy (PFR)|BEHAVIORAL: Conventional group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation
Status: UNKNOWN
Conditions: Pediatric Patients Undergoing Allogeneic Cord Blood Transplantation.
Interventions: DRUG: eltrombopag
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TissuePAtchDS--P ™ PArotidectomy Trial.
Status: TERMINATED
Conditions: Parotid Gland Disorders
Interventions: DEVICE: TissuePatchDS-P™|DEVICE: Surgical Drain
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Predicting Obesity Consequences Using Body Measure and Urine Metabolomics
Status: UNKNOWN
Conditions: Non-Alcoholic Fatty Liver Disease|Body Composition|Electric Impedance
Interventions: DIAGNOSTIC_TEST: Fibroscan|DIAGNOSTIC_TEST: Bioelectrical impedance analysis|DIAGNOSTIC_TEST: Urine unclear magnetic resonance metabolomics|DIAGNOSTIC_TEST: Hand grip strength
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
Status: COMPLETED
Conditions: Dyslipidemias
Interventions: DRUG: Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen
Status: COMPLETED
Conditions: Rabies
Interventions: BIOLOGICAL: PVRV|BIOLOGICAL: PVRV and pERIG Favirab®|BIOLOGICAL: PVRV and pERIG Favirab®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
Status: UNKNOWN
Conditions: Hepatocellular Carcinoma
Interventions: DRUG: Cabozantinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Anxiety Self-management Intervention for Pulmonary Hypertension
Status: UNKNOWN
Conditions: Pulmonary Hypertension|Pulmonary Arterial Hypertension|Anxiety|Anxiety Disorders
Interventions: OTHER: Cognitive Behavioural therapy self help intervention for anxiety
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain
Status: COMPLETED
Conditions: Dyslipaemia|Atherosclerosis Risk|Increased hsCRP|Inflammatory and Oxidative Status in the Spanish Population
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19
Status: RECRUITING
Conditions: Post-COVID Syndrome
Interventions: BEHAVIORAL: Complementary and Integrative Medicine online intervention, routine care and book|BEHAVIORAL: Routine care and book
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect Of Intravenous Hyoscine -N-Butyl Bromide In Management Of Prolonged Labor In Nulliparous
Status: COMPLETED
Conditions: Prolonged Labor
Interventions: DRUG: Hyoscine N Butylbromide|DRUG: Normal Saline 0.9%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation
Status: COMPLETED
Conditions: Gastric Ulcer
Interventions: DRUG: Rebamipide and Omeprazole|DRUG: Omeprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma
Status: WITHDRAWN
Conditions: Endometrial Neoplasms
Interventions: DRUG: Ponatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: SPOON: Sustained Program for Improving Nutrition - Mexico
Status: WITHDRAWN
Conditions: Exclusive Breastfeeding|Feeding Patterns|Stunting|Obesity, Childhood
Interventions: DIETARY_SUPPLEMENT: SQ-LNS|BEHAVIORAL: SPOON behavioral change strategy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease
Status: COMPLETED
Conditions: Alzheimer Disease
Interventions: DEVICE: Vielight Neuro Gamma|OTHER: Sham Vielight Neuro Gamma
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: TRISCEND II Pivotal Trial
Status: RECRUITING
Conditions: Tricuspid Valve Regurgitation|Tricuspid Valve Insufficiency|Tricuspid Valve Disease|Heart Valve Diseases|Cardiovascular Diseases|Heart Failure
Interventions: DEVICE: Edwards EVOQUE System|DRUG: Optimal Medical Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery
Status: NOT_YET_RECRUITING
Conditions: Neuromuscular Blockade
Interventions: DRUG: SUGAMMADEX SODIUM 100 Mg in 1 mL|DRUG: Neostigmine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography
Status: COMPLETED
Conditions: Insomnia|Sleep Initiation and Maintenance Disorders
Interventions: DRUG: zolpidem
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Conditions: Solid Tumor
Interventions: DRUG: BGB-B167|DRUG: Tislelizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Status: COMPLETED
Conditions: Atrial Fibrillation or Pulmonary Embolism|Need of Long Term Oral Anticoagulation Therapy (OAT)|Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Interventions: DRUG: Rivaroxaban or Marcumar
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
Status: COMPLETED
Conditions: Type 1 Diabetes
Interventions: OTHER: Pre-exercise meal|OTHER: Pre-exercise meal
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Status: UNKNOWN
Conditions: Nasopharyngeal Carcinoma
Interventions: DRUG: gemcitabine and cisplatin (Induction chemotherapy)|RADIATION: IMRT and concurrent cisplatin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia
Status: COMPLETED
Conditions: Spinal Anesthesia
Interventions: DRUG: chloroprocaine|DRUG: bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Status: COMPLETED
Conditions: Schizophrenia|Schizoaffective Disorder|Depressive Disorder, Major|Bipolar Disorder
Interventions: DRUG: olanzapine versus risperidone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Muscle Oxygenation and Skin Pigmentation
Status: WITHDRAWN
Conditions: Muscle Oxygenation|Skin Pigmentation
Interventions: DEVICE: Measure of muscle oxygenation|DEVICE: Skin pigmentation determination
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.
Status: COMPLETED
Conditions: Aortic Valve Disease|Aortic Aneurysm
Interventions: DEVICE: MRI
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC